510(k) device
Precision GI
Limaca Medical, Ltd. · Biopsy Needle (FCG, Class II) · First FDA decision Aug 28, 2023, newest Aug 28, 2023Cancer detection and genomic testing
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
1
Naming "Precision GI"
MAUDE reports
0
Brand "Precision GI", since 2015
PubMed studies
1
Mentioning "Precision GI"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Precision GI
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Precision GIBreakthrough510(k)
K231422 · Decided Aug 28, 2023 · 103 days after receipt
Device type: Biopsy Needle (FCG) · GI, Urology & Nephrology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Precision GI", any status and sponsor, newest update first.
- Artificial Intelligence in ColonoscopyPivotal-lookingCompleted
Pankaj PatelAcademic, hospital or other
NCT06621225 · 264 participants · Start Nov 22, 2022 · Primary completion May 31, 2023
Device: Artificial Intelligence; Mucosal Exposure Device · For: Colorectal Carcinoma
Sites: Sebring, Florida
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Precision GI", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code FCG
4,062 reports: 3,169 malfunction, 865 injury, 22 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Precision GI"[tiab]. The summary above synthesizes these.
- Application of a novel endoscopic ultrasound-guided motorized fine needle for liver and pancreatic lesion biopsy.
Baquerizo-Burgos J, Del Valle R, Egas-Izquierdo M, et al. · VideoGIE · 2026
Other devices of this type
Also filed under product code FCG.
- Single Use Aspiration Needle NA-U401SX-4025/NA-U401SX-4025NOlympus Medical Systems Corp. · 510(k) 2018
- Echotip Ultra Endobronchial High Definition Ultrasound NeedleCook Ireland, Ltd. · 510(k) 2016
- Sonotip II Ultrasound Needle SystemMedi-Globe Corporation · 510(k) 2007
- Easy Core Biopsy System IIBoston Scientific Corp · 510(k) 2005
- Single-Use Fine Needle Biopsy (FNB) device (NA-U210H)Olympus Medical Systems Corp. · 510(k) 2025
- ClearTip FNA and FNB TypesFinemedix Co., Ltd. · 510(k) 2025
- EchoTip AcuCore EUS Biopsy Needle (ECHO-BX-19)Cook Ireland, Ltd. · 510(k) 2024
- ClearTipFinemedix Co., Ltd. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.